Clinical Trial Update: Linking Altered Central Pain Processing and Genetic Polymorphism to Drug Efficacy in Chronic Low Back Pain (Predictio) [Phase 3]

View source ↗

Summary

This Phase 3 trial update examines how altered central pain processing and a genetic polymorphism relate to drug efficacy in chronic low back pain, with the stu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Low Back Pain

Snippet

Sponsor: Insel Gruppe AG, University Hospital Bern | Conditions: Low Back Pain | Phase 3 | Status: COMPLETED